Clinical Trial Update: Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety of intravenous oritavancin for treating skin infections in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Drugs mentioned

• Dalvance (dalbavancin)

Snippet

Sponsor: Melinta Therapeutics, LLC | Conditions: Acute Bacterial Skin and Skin Structure Infection | Phase 2 | Status: COMPLETED